Agitation-induced aggregation and subvisible particulate formation in model proteins

Wang, 2010, Protein aggregation–pathways and influencing factors, Int. J. Pharm., 390, 89, 10.1016/j.ijpharm.2010.02.025 Hawe, 2009, Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress, Eur. J. Pharm. Sci., 38, 79, 10.1016/j.ejps.2009.06.001 Nayak, 2011, Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution, J. Pharm. Sci., 100, 4198, 10.1002/jps.22676 Barnard, 2011, Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway, J. Pharm. Sci., 100, 492, 10.1002/jps.22305 Gupta, 1994, Approaches to reducing subvisible particle counts in lyophilized parenteral formulations, J. Pharm. Sci. Technol., 48, 30 Scherer, 2012, Issues and challenges of subvisible and submicron particulate analysis in protein solutions, AAPS J., 14, 236, 10.1208/s12248-012-9335-8 Wang, 2012, Immunogenicity of protein aggregates – concerns and realities, Int. J. Pharm., 431, 1, 10.1016/j.ijpharm.2012.04.040 Curatolo, 1997, Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation, Cytokine, 9, 734, 10.1006/cyto.1997.0228 Poon, 2009, Amyloidogenicity and aggregate cytotoxicity of human glucagon-like peptide-1 (hGLP-1), Protein Pept. Lett., 16, 1548, 10.2174/092986609789839232 Kayed, 2003, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science, 300, 486, 10.1126/science.1079469 Carpenter, 2009, Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality, J. Pharm. Sci., 98, 1201, 10.1002/jps.21530 Carpenter, 2002, Long-term storage of proteins, 4.6.1 Mahler, 2005, Induction and analysis of aggregates in a liquid IgG1-antibody formulation, Eur. J. Pharm. Biopharm., 59, 407, 10.1016/j.ejpb.2004.12.004 Kiese, 2008, Shaken, not stirred: mechanical stress testing of an IgG1 antibody, J. Pharm. Sci., 97, 4347, 10.1002/jps.21328 Eppler, 2010, Relevant shaking stress conditions for antibody preformulation development, Eur. J. Pharm. Biopharm., 74, 139, 10.1016/j.ejpb.2009.11.005 Carpenter, 1999, Inhibition of stress-induced aggregation of protein therapeutics, Methods Enzymol., 309, 236, 10.1016/S0076-6879(99)09018-7 Wang, 2005, Protein aggregation and its inhibition in biopharmaceutics, Int. J. Pharm., 289, 1, 10.1016/j.ijpharm.2004.11.014 Demeule, 2007, Detection and characterization of protein aggregates by fluorescence microscopy, Int. J. Pharm., 329, 37, 10.1016/j.ijpharm.2006.08.024 Mahler, 2009, Protein aggregation: pathways, induction factors and analysis, J. Pharm. Sci., 98, 2909, 10.1002/jps.21566 Joubert, 2011, Classification and characterization of therapeutic antibody aggregates, J. Biol. Chem., 286, 25118, 10.1074/jbc.M110.160457 Molecular Operating Environment (MOE), Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2011. Wildman, 1999, Prediction of physiochemical parameters by atomic contributions, J. Chem. Inf. Comput. Sci., 39, 868, 10.1021/ci990307l Singh, 2012, Monitoring of subvisible particles in therapeutic proteins, Methods Mol. Biol., 899, 379, 10.1007/978-1-61779-921-1_24 Hu, 2011, Investigation of protein conformational stability employing a multimodal spectrometer, Anal. Chem., 83, 9399, 10.1021/ac201995c Fesinmeyer, 2009, Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies, Pharm. Res., 26, 903, 10.1007/s11095-008-9792-z Saluja, 2010, Diffusion and sedimentation interaction parameters for measuring the second virial coefficient and their utility as predictors of protein aggregation, Biophys. J., 99, 2657, 10.1016/j.bpj.2010.08.020 Sharma, 2010, Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations, AAPS J., 12, 455, 10.1208/s12248-010-9205-1 Zhang, 2012, Protein G, protein A and protein A-derived peptides inhibit the agitation induced aggregation of IgG, Mol. Pharm., 9, 622, 10.1021/mp200548x Thirumangalathu, 2009, Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution, J. Pharm. Sci., 98, 3167, 10.1002/jps.21719 Abbas, 2012, Opposite effects of polyols on antibody aggregation: thermal versus mechanical stresses, Pharm. Res., 29, 683, 10.1007/s11095-011-0593-4 Chennamsetty, 2009, Design of therapeutic proteins with enhanced stability, Proc. Natl. Acad. Sci. USA, 106, 11937, 10.1073/pnas.0904191106 Philo, 2006, Is any measurement method optimal for all aggregate sizes and types?, AAPS J., 8, E564, 10.1208/aapsj080365 Ahrer, 2004, Detection of aggregate formation during production of human immunoglobulin G by means of light scattering, J. Chromatogr. A, 1043, 41, 10.1016/j.chroma.2004.05.024 Chi, 2003, Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation, Pharm. Res., 20, 1325, 10.1023/A:1025771421906 Zhang, 2008, How native proteins aggregate in solution: a dynamic Monte Carlo simulation, Biophys. Chem., 133, 71, 10.1016/j.bpc.2007.12.008 Park, 2013, Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying, Pharm. Res., 30, 968, 10.1007/s11095-012-0933-z Ahmad, 2005, Guanidine hydrochloride denaturation of human serum albumin originates by local unfolding of some stable loops in domain III, Biochim. Biophys. Acta, 1750, 93, 10.1016/j.bbapap.2005.04.001 Hawe, 2008, Extrinsic fluorescent dyes as tools for protein characterization, Pharm. Res., 25, 1487, 10.1007/s11095-007-9516-9 Yadav, 2010, Specific interactions in high concentration antibody solutions resulting in high viscosity, J. Pharm. Sci., 99, 1152, 10.1002/jps.21898 Yadav, 2012, Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects, J. Pharm. Sci., 101, 998, 10.1002/jps.22831 Munch, 2010, Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants, J. Mol. Biol., 399, 512, 10.1016/j.jmb.2010.04.019 Kayser, 2011, Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and thioflavin T binding, MAbs, 3, 408, 10.4161/mabs.3.4.15677 Curry, 1999, Fatty acid binding to human serum albumin: new insights from crystallographic studies, Biochim. Biophys. Acta, 1441, 131, 10.1016/S1388-1981(99)00148-1 Michnik, 2006, Comparative DSC study of human and bovine serum albumin, J. Therm. Anal. Calorim., 84, 113, 10.1007/s10973-005-7170-1 Arai, 1999, Reversibility and hierarchy of thermal transition of hen egg-white lysozyme studied by small-angle X-ray scattering, Biophys. J., 76, 2192, 10.1016/S0006-3495(99)77374-1 Garber, 2007, A broad range of Fab stabilities within a host of therapeutic IgGs, Biochem. Biophys. Res. Commun., 355, 751, 10.1016/j.bbrc.2007.02.042 Sanchez-Ruiz, 2011, Probing free-energy surfaces with differential scanning calorimetry, Annu. Rev. Phys. Chem., 62, 231, 10.1146/annurev-physchem-032210-103504 Farruggia, 2001, The participation of human serum albumin domains in chemical and thermal unfolding, J. Protein Chem., 20, 81, 10.1023/A:1011000317042 Vermeer, 2000, The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein, Biophys. J., 78, 394, 10.1016/S0006-3495(00)76602-1 Ahrer, 2006, Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering, J. Biochem. Biophys. Methods, 66, 73, 10.1016/j.jbbm.2005.12.003 Gunther, 2011, Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung, Eur. J. Pharm. Biopharm., 77, 438, 10.1016/j.ejpb.2010.11.007 Niesen, 2007, The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability, Nat. Protoc., 2, 2212, 10.1038/nprot.2007.321 He, 2010, High throughput thermostability screening of monoclonal antibody formulations, J. Pharm. Sci., 99, 1707, 10.1002/jps.21955 Jahn, 2008, Folding versus aggregation: polypeptide conformations on competing pathways, Arch. Biochem. Biophys., 469, 100, 10.1016/j.abb.2007.05.015 Narhi, 2012, Classification of protein aggregates, J. Pharm. Sci., 101, 493, 10.1002/jps.22790 Philo, 2009, Mechanisms of protein aggregation, Curr. Pharm. Biotechnol., 10, 348, 10.2174/138920109788488932 Lilyestrom, 2013, Monoclonal antibody self-association, cluster formation, and rheology at high concentrations, J. Phys. Chem. B, 117, 6373, 10.1021/jp4008152 Kiese, 2010, Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation, J. Pharm. Sci., 99, 632, 10.1002/jps.21858 Sahin, 2010, Comparative effects of pH and ionic strength on protein–protein interactions, unfolding, and aggregation for IgG1 antibodies, J. Pharm. Sci., 99, 4830, 10.1002/jps.22198 Banks, 2012, Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies, J. Pharm. Sci., 101, 2720, 10.1002/jps.23219